{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:28:58Z","timestamp":1754483338643,"version":"3.40.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The study aims to evaluate the characteristics, treatments, and incidence rates of carpal tunnel syndrome (CTS) and tenosynovitis in women with breast cancer, according to the hormone therapy used. We retrospectively reviewed women with breast cancer identified from the clinical data warehouse of the six hospitals in Korea, from January 2015 to August 2020. Among them, patients with CTS or tenosynovitis were reviewed in terms of disease status and treatments. A total of 101 patients among a population of 15,504 met the study inclusion criteria, so their clinical data were analyzed. Aromatase inhibitor (AI) users frequently needed oral medication for CTS, and developed severe CTS which frequently required surgery. AI users presented with a higher incidence of CTS (1.3%) than patients without hormone therapy (0.4%), and tenosynovitis occurred at a higher rate in AI users (2.3%) compared to the tamoxifen (1.1%) and no hormone groups (0.5%). More than half of the CTS and tenosynovitis occurred within 12\u200amonths after hormone commencement. The incidence and disease characteristics of CTS and tenosynovitis differed among the groups depending on the type of hormone therapy received. Our findings will help clinicians understand clinical courses and treatments for CTS and tenosynovitis in breast cancer patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028786","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:04:31Z","timestamp":1643979871000},"page":"e28786","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Carpal tunnel syndrome and tenosynovitis in women with breast cancer associated with hormone therapy"],"prefix":"10.1097","volume":"101","author":[{"given":"Dong Jae","family":"Shin","sequence":"first","affiliation":[{"name":"Departments of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Eun","family":"Nam","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Heon","family":"Song","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"Im","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Jae","family":"Won","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo Hyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hoon","family":"Lim","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-4807","authenticated-orcid":false,"given":"Jong In","family":"Lee","sequence":"additional","affiliation":[{"name":"Departments of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Gradishar","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e000523","DOI":"10.1136\/rmdopen-2017-000523","article-title":"Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology","volume":"3","author":"Caprioli","year":"2017","journal-title":"RMD Open"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","article-title":"Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors","volume":"111","author":"Henry","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ctrv.2007.10.004","article-title":"Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations","volume":"34","author":"Coleman","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/annonc\/mds290","article-title":"Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data","volume":"24","author":"Lintermans","year":"2013","journal-title":"Ann Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00520-015-3001-5","article-title":"Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options","volume":"24","author":"Lombard","year":"2016","journal-title":"Support Care Cancer"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2017.01.010","article-title":"Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: a systematic review and meta-analysis","volume":"111","author":"Roberts","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/jcm9020566","article-title":"Aromatase inhibitors and risk of arthritis and carpal tunnel syndrome among Taiwanese women with breast cancer: a nationwide claims data analysis","volume":"9","author":"Chien","year":"2020","journal-title":"J Clin Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00280-016-3190-8","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice","volume":"78","author":"Labidi","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(11)70328-X","article-title":"Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2\u20133\u200ayears of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study","volume":"13","author":"Mieog","year":"2012","journal-title":"Lancet Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2009.22.0236","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial","volume":"27","author":"Sestak","year":"2009","journal-title":"J Clin Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.2015.63.4972","article-title":"Anastrozole-induced carpal tunnel syndrome: results from the international breast cancer intervention study II prevention trial","volume":"34","author":"Spagnolo","year":"2016","journal-title":"J Clin Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/mus.10185","article-title":"Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement","volume":"25","year":"2002","journal-title":"Muscle Nerve"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1388-2457(02)00169-4","article-title":"Carpal tunnel syndrome: pathophysiology and clinical neurophysiology","volume":"113","author":"Werner","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.apmr.2015.09.013","article-title":"Clinical course and prognostic factors in conservatively managed carpal tunnel syndrome: a systematic review","volume":"97","author":"Burton","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellbi.2007.08.014","article-title":"Estrogen and progesterone receptors in carpal tunnel syndrome","volume":"32","author":"Toesca","year":"2008","journal-title":"Cell Biol Int"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.17712\/nsj.2017.3.20160638","article-title":"Clinical and electrophysiological evaluation of carpal tunnel syndrome: approach and pitfalls","volume":"22","author":"Alanazy","year":"2017","journal-title":"Neurosciences (Riyadh)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mus.23824","article-title":"Grading severity of carpal tunnel syndrome in electrodiagnostic reports: why grading is recommended","volume":"48","author":"Sucher","year":"2013","journal-title":"Muscle Nerve"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cnp.2018.02.005","article-title":"Nerve conduction studies and EMG in carpal tunnel syndrome: do they add value?","volume":"3","author":"Sonoo","year":"2018","journal-title":"Clin Neurophysiol Pract"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1200\/JCO.2008.20.5435","article-title":"Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia","volume":"27","author":"Dizdar","year":"2009","journal-title":"J Clin Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1200\/JCO.2007.15.4005","article-title":"Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome","volume":"26","author":"Morales","year":"2008","journal-title":"J Clin Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3803\/EnM.2017.32.1.90","article-title":"Development of clinical data mart of HMG-CoA reductase inhibitor for varied clinical research","volume":"32","author":"Kim","year":"2017","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:20Z","timestamp":1746331640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028786"}},"subtitle":["A multi-institutional analysis using a clinical data warehouse"],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028786","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"2021-10-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}